Viewing Study NCT07173933

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-02-01 @ 4:50 PM
Study NCT ID: NCT07173933
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-15
First Post: 2025-09-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD)
Sponsor: GeneCradle Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Wilson Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gene therapy View
None Genecradle View
None AAV5 View
None ATP7B View
None Wilson Disease View